As of 2012, the cord blood banking industry is one of the fastest growing
industries in the world. There were only 23 active cord blood banks as of
2005, and now just 7 years later, there are 485 worldwide. Cord blood banks
now exist in nearly every developed country, as well as several developing
nations. That is a 21-fold increase (2,100%) in the companies involved in the
industry, over only a seven year period.
Within the United States, cord blood banks have appeared in nearly every
state. Furthermore, the U.S. cord blood banking industry is the most mature
cord blood banking market in the world, having the:
- First company to offer cord blood storage (1995)
- First company to offer cord tissue storage (2010)
- Largest total number of industry participants (both public and private)
- Most number of cord blood units (CBU) stored
- Most cord blood units banked proportional to population
This rapid market growth represents both an opportunity to profit, as well as
A Fast-Growth Industry, Driven by Medical Necessity and Consumer Demand
The field of cord blood banking is a fast-growth field, driven by medical
necessity and consumer demand. It is also a recent industry, as it was not
until 1974 that it was first proposed that stem and progenitor cells were
present in human cord blood and 1983 that umbilical cord blood was proposed as
an alternative source of stem cells for transplant. In 1988, the first
successful cord blood transplant occurred, but it was not until 1995 that the
first private cord blood bank began operations.
Furthermore, it was not until July, 2010, when the Cord Blood Registry became
the first private U.S. cord blood bank to offer umbilical cord tissue storage.
In the two years that have since passed then, the number of private U.S. cord
blood banks offering cord tissue storage has risen to nine. This represents an
average of one new U.S. cord blood bank adding cord tissue storage every 3
months. If this rate continues, half of all private U.S. cord blood banks will
offer cord tissue storage within two years.
Since the first cord blood transplant was performed in 1988, stem cells
derived from umbilical blood have been used in more than 30,000 transplants
worldwide to treat a wide range of blood diseases, genetic and metabolic
disorders, immunodeficiencies and various forms of cancer. However, there is
still significant variation within the industry. There is the divide between
private and public cord blood banking, in which private companies serve
individual families, while public banks serve the broader public.
Additionally, some cord blood banks receive only units from nearby hospitals
and birthing centers, while others allow mail-in units from a wide geographic
There is also variation in the services offered by private cord blood banks,
as some companies only offer cord blood storage only and others offer it in
conjunction with cord tissue storage. Finally, there is also significant
variation in the quality, pricing and guarantees promised by cord blood banks.
Report Format and Key Findings
In this comprehensive 2012 industry report, you'll learn:
Part 1: U.S. Cord Blood Banking Industry - Market Overview & Outlook
The first section of the report “roots” where the cord blood
banking industry has been, what has shaped it, and where it is going. Using
both qualitative and quantitative assessment, it explores critical timeline
events, current and future conditions treatable, advantages of cord blood
transplant, probabilities of requiring stem cell transplant throughout the
lifespan, and more. With this detailed knowledge, you can know the relative
strength of your position within the marketplace.
Part 2: Expansion and Growth - Trailing 12-Month Analysis & Forward
The second section explores where the U.S. cord blood banking industry is now
and what you should anticipate for the near-term future, based on recent
trends and five-year projections. Critically, it explores strategies of
fast-growth U.S. companies and compares their actions and attributes to
slow-growth companies, providing a comprehensive road-map to industry
Furthermore, detailed assessment of U.S. cord blood industry trends are
presented in this section, including:
- Rates of cord blood storage
- Rates of parental awareness
- Trends in medical opinions of cord blood banking
- Quantitative analysis of cord blood grant funding, publication rates, and
- And much more
Part 3: Comprehensive Parent Survey - Continuing to Grow by Listening
to Expectant Parents
While the last section showed you what to expect if trends continue as they
are and revealed the environment that you will find yourself in within the
next five years, this final section is your guide to taking strategic action
and controlling your competitive position.
This section contains findings from a detailed survey that reveals how U.S.
parents learn about cord blood banking, think about the process, and make key
decisions. This survey is your insight into the mind of your prospective
clients. Key findings from the survey include how to:
- Strategically position your products
- Understand why expectant parents bank publicly, privately, or not at all
- Communicate successfully with parents
- Effectively educate parents
- Prioritize your advertising budget
- Sell your services more effectively
In summary, this section is your guide to growing, expanding, and profiting,
by listening to the needs of your clients - expectant parents within the U.S.
Your Roadmap to the Next 5 Years
Over the past 12 months, the cord blood banking industry has expanded through
double digit growth, due to new entrants in the cord blood banking industry,
as well as revenue growth at existing operations. To guide industry
competitors, this report carefully considers the following questions:
- What factors are causing a substantial number of new cord blood banks to
open up business?
- What will be the effect of these new entrants to the cord blood banking
- How can existing competitors maintain a position of dominance among this
Deeper analysis also reveals that existing cord blood banks follow a bi-modal
distribution, either experiencing flat-line growth (less than 3% per annum) or
substantively building revenue (25% or more per annum).
While a similar bimodal distribution existed in the prior 12 month period
(trailing 12 to 24 months), the peaks have continued to separate over the past
12 months, with the average flat-growth company staying stagnant and the
average revenue growth company increasing its per annum growth rate from 17%
per year to 25% per year. This trend indicates an increasing shift in
dominance toward fast-growth companies, which begs the questions:
- What are the differences among the cord blood banks that are experiencing
flat-line growth, versus those that have substantively building revenue?
- Why are the fast-growth companies continuing to increase their dominance
relative to the flat growth companies?
Why Claim the Complete 2012 U.S. Cord Blood Banking Industry Report?
As mentioned above, this industry report is a comprehensive road-map for
operating a successful cord blood bank. It takes you from the where the
industry has been, to where it is now, to where is is going in the next five
years. In addition, it gives you insider knowledge of how expectant parents
think, so you can get there fast.
It teaches you - management of a private cord blood bank - how to
strategically position your services to increase market share and attract
expectant parents to your company.
Rather than focusing on the “medical” and “technical”
aspects of cord blood stem cells, the report focuses on the practical and
strategic applications necessary to successfully run a private cord blood
bank. While the medical angle is interesting, you already know that part of
you business. It would tell you nothing about strategic actions to take to
have more expectant parents purchasing services from you, instead of the
Instead, this industry report is focused on your needs and includes content
relevant to what you want to know - how to optimally price your services,
criteria that make expectant parents likely to purchase private cord blood
banking services, and how to grow in a competitive industry.
Like it or not, the cord blood banking industry is getting more and more
competitive every day. By doing nothing, clients will likely be won over by
better informed, or simply more aggressive, competitors.
The Many Benefits to You
BioInformant only produce stem cell industry data. Because stem cells are
richly populated in cord blood, we have been tracking the cord blood industry
since 2005, when it was an early stage market. Unlike BioInformant, other
publishers of cord blood data are broad range publishers without expertise in
any specific area - this limits their ability to produce exactly what you need.
We do understand the nuances of your business, because we have been analyzing
your industry since 2005.
7 Years of Extensive Research & Experience
When we started tracking the cord blood banking industry seven years ago there
were only 23 active cord blood banks. There are now 485 worldwide. That is a
21-fold increase (2,100%) in the number of companies involved within this
industry, over only a seven year period.
Within the United States, there are now 70 active public and private cord
blood banks, spread across nearly every U.S. state.
Understanding the drastic increase in the quantity of competition makes it
clear why you would benefit from the trends, market intelligence, and industry
data in this report.
Substantiated Future Projections
We track this cord blood banking industry meticulously, year-after-year
producing more revealing and accurate data. With great interest, we have
annually identified the most successful industry participants and done careful
study of the commonalities that exist among this group. We treat these
companies as “models” for successful cord blood banking operation.
With equally great interest, we have also annually identified the least
successful cord blood companies and done careful study to identify the
commonalities that exist among this group. We treat these companies as
“warnings” for how to not operate a cord blood bank, unless the
goal is to run it into the ground.
In this report, we present our detailed findings for your benefit - we give
you the road-map for how to be a fast-growth cord blood bank, so you can avoid
the fate of a flat-growth company.
Optimal Foundation For Future Projections
Our historical knowledge of the cord blood industry also means that we have
seven years of trailing data on the industry, and are therefore, are optimally
positioned to provide you with forward projections for the industry.
While no one can predict the future with 100% certainty, our foundation of
knowledge means that we have the greatest likelihood of accurately predicting
future trends and growth within the cord blood banking industry.
Make More Money
We are the only producer of data specific for cord blood banks that actually
teaches you how to effectively sell your services, strategically position your
products, and make more money.
Serving The Industry Elite
In a cut-throat industry, you need to access the tools that you competition
already has. Because BioInformant has been the leading supplier of cord blood
industry data since 2005, we have already served most of the world's leading
private cord blood banks.
Existing clients of ours include: The Virgin Health Bank, Canadian Blood
Services, Cryo-Save AG, Insception Cord Blood Bank, StemCyte Inc., The New
York Blood Center, Xytex Corporation, Cells For Life, SmartBank, NHS Cord
Blood Bank (NHBTS), Secuvita, Eurocord, Neostem, Cord Life Singapore,
Thermogenesis, Biosafe SA, Cryo-Save, The Till Group, Precious Cells, the
National Marrow Donor Program (NMDP), and many more.
Serving The Rest of The Industry Too
While our sole focus has been on producing high quality market intelligence
targeted for head management of private cord blood banks, we were surprised to
find that a range of other companies also require reputable, accurate, and
substantiated data for the cord blood industry.
These companies either expect to launch cord blood banking services, or they
are interested in investing in companies within the cord blood industry, or
they are interested in selling services to cord blood facilities. To this end,
we often serve biotech venture capitalists, strategic consultancy companies,
and healthcare organizations.
You Need Access To The Tools Your Competition Already Has
Other companies in the cord blood industry have already claimed this report
and are implementing actions based on it. Can you afford to let them have that
edge in an industry that has grown 21-times more competitive over the past
Direct Insight Into The Minds of Your Clients
This is the only cord blood industry market report available that includes
direct insight (survey results) into the minds of expectant parents - your
clients. We have interviewed more than 567 U.S. expectant parents in order to
understand how they view cord blood banking services.
We have explored how they perceive the benefits and drawbacks, how they
describe their fears and motivations, and how they describe the
decision-making process. We have captured this invaluable insight for you in
Section 3 of the report - "Comprehensive Parent Survey - Continuing to Grow by
Listening to Expectant Parents (567 Respondents)".
What You Can Expect
1) Increase Your Customer Base - Have more parents electing to use your
cord blood banking services when you strategically understand your industry.
2) Become a Strategic Leader - Leverage this valuable, detailed, and
rare information to ensure that you are fully equipped with the necessary
information to successfully lead you company and achieve desired results.
3) Increase Profits - Make more profit while putting forth less effort
4) Industry Security - Be able to both survive and thrive in the cord
blood banking industry, even as it becomes much more competitive. Can you
survive if the quantity of your competition doubles again? It is likely to
5) Crush Competition - Be able to take away market share from the
competition as you gain a strategic “edge”.
Table of Contents
PART 1: U.S. Cord Blood Banking Industry - Market Overview & Outlook
I. Timeline of Critical Events in U.S. Cord Blood Banking
II. Likelihood of Needing a Stem Cell Transplant
- A. Childhood Probability
- B. Adult Probability
- C. Full Life-Span Analysis
III. Current, Near-Term, and Projected Conditions Treatable with Cord Blood Transplant
- A. Categories of Disease Treatable With Cord Blood Transplant
- B. Existing Conditions
- C. Near-Term Conditions
- 1. Human Trials
- 2. Laboratory Trials
- D. Projected Conditions
IV. Cord Blood vs. Bone Marrow and Peripheral Blood, as a Source of Stem Cells for Transplant
V. Cord Blood Banking - Storage Options
- A. Private Banks
- B. Public Banks
- 1. Free Programs for U.S. Families in Medical Need
- 2. U.S. Mail-in Donation (Public) Cord Blood Banks
- C. International Summary and Comparison
PART 2: Expansion and Growth - Trailing Twelve Month Analysis & Forward Projections
I. Fast-Growth vs. Flat-Growth - Bimodal Distribution
II. Growth Rate
- A. Flat-line growth companies (< 3% per year)
- B. Substantive revenue growth companies (25% or more per year)
IV. Industry Conditions - North America
- A. Canada
- B. United States
- C. Mexico
- A. Rates of Worldwide Cord Blood Storage (Units per Year)
- B. Rates of Parental Awareness
- C. Medical Society Opinions of Cord Blood Banking
- D. Cord Blood Research Publication Rates
- E. Cord Blood Research Funding Levels (Grant Analysis)
- F. Cord Blood Patent Breakdown
- G. Rates of Cord Blood Research Product Development
- H. Top Countries for Cord Blood Research
- I. Cord Blood Conferences & Events
VI. Cord Tissue Storage
- A. Overview of Cord Blood Storage vs. Cord Tissue Storage
- B. Pricing of Cord Tissue Storage
- C. Clinical Trials - Cord Blood vs. Cord Tissue
- D. Market Penetration of Cord Tissue Storage
VII. Barriers to Entering the U.S. Cord Blood Market
- A. Accreditation
- 1. Types of Accreditation
- 2. AABB Overview
- 3. ABB Accredited Cord Blood Banks
- 4. Current Conditions
- a. Rise in cGTP and cGMP Compliance Consultancy
- b. Single Entity Expansion
- B. Security requirements
- C. Laboratory and storage requirements
- D. Legislation
VIII. Leveraging Novel Tactics for Substantive Revenue Growth
- A. Strategic Collaborations
- 1. Regional Hospitals and Birthing Centers
- a. Public Banking System
- b. Private Banking System
- 2. Broad-Spectrum Collaborations
- B. Careful Selection of Region
- C. Establishing Credentials - Indicators of Reputability
(Accreditation, Licensure, Transplant Track Records)
- D. Merger and Acquisition Potential
- E. Multi-National Marketing Framework
- F. Parental Referral Programs
- G. Effective Communication of Cord Blood Banking Services
- H. Rapid Integration of New Technologies
- I. Low-Cost Operating Environment
- J. Government Support and Affiliation
- K. Utilizing Third-Party Cryogenic Storage Facilities
- L. Capital Resources
IX. Comparing to the Competition - Setting Yourself Apart
- A. Ten Largest U.S. Cord Blood Banks - Pricing and Characteristics
- B. Cost Variation
- C. Accreditation Standards for U.S. Cord Blood Banks
- D. Technical Variables
- 1. Vapor-Phase Storage vs. Liquid-Phase Storage
- 2. Cryo-bags vs. Cryo-vials
- 3. Pentastarch vs. Hetastarch
- 4. Computer Controlled vs. Manual Rate Freezing
- 5. Whole Sample vs. Volume Reduction
- E. Corporate Variables
- 1. Corporate Stability
- 2. Scientific Expertise
PART 3: Parent Survey - Continuing to Grow by Listening to Expectant Parents
I. Expectant Parent Survey
- A. Characteristics of Survey Respondent Population
- B. Survey Results - Respondents Who Banked Cord Blood Privately
- C. Survey Results - Respondents Who Banked Cord Blood Publicly
- D. Survey Results - Respondents Who Did Not Bank Cord Blood
- E. Survey Results - All Respondents
II. Summary of Conclusions
- Appendix A - Existing Conditions Treatable with Cord Blood
- Appendix B - Global List of Cord Blood Banks, 2012
- Appendix C - AABB Accredited Cord Blood Banks Worldwide, 2012
- Appendix D - Accreditation Standards by U.S Cord Blood Bank, Public
- Appendix E - Cord Blood Stem Cell Legislation by U.S. State
Complete 2012-13 U.S. Cord Blood Banking Industry Report published by BIOINFORMANT WORLDWIDE, LLC in July 20, 2012. This report consists of 175 Pages and the price starts from US $ 3995.